Moffitt Cancer Center, an incredibly famous cancer treatment and research center, and Fulgent Pharma, a nanobiotechnology firm, reported an essential organization pointed toward propelling cancer treatment through clinical turn of events and...
Fulcrum Therapeutics, Inc., a biotechnology firm declared that it has signed a collaboration and license agreement with Sanofi to develop and commercialize losmapimod, an oral small molecule being studied for the treatment of facioscapulohumeral...
Digital leaders and major players of the whole value chain gather at Pharmaceutical Automation and Digitalisation Congress (AUTOMA+ 2024) to share professional opinion on trends and latest solutions for the pharma digital transformation.
Zai Lab Limited, a biotechnology firm, declared that the National Medical Products Administration (NMPA) in China has endorsed the New Drug Application (NDA) for Augtyro (repotrectinib) for the therapy of grown-up patients with privately...
Sanofi, a leading pharmaceutical and healthcare firm, reports a venture of more than €1 billion to establish a new bioproduction limit at its locales in Vitry-sur-Seine (Val de Marne), Le Quality (Seine-Oceanic) and Lyon Gerland (Rhône)...
The US Food and Drug Administration has granted full clearance to Seagen Inc.'s Tivdak (tisotumab vedotin), which targets tissue factor (TF), for the treatment of patients with recurrent or metastatic cervical cancer who have progressed during or...
Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Sevelamer Carbonate Tablets, 800 mg, from the USFDA
Intensity Therapeutics, Inc., a biotechnology firm, declares that the organization executed an alliance with The Swiss Group for Clinical Cancer Research (SAKK) to lead a stage 2 randomized (coordinated), controlled preliminary assessing clinical...
Mabwell Therapeutics, a biotechnology firm, reported that its self-created novel Nectin-4-focusing on ADC (Research and development code: 9MW2821) has been conceded Orphan Drug Designation (ODD) by the US FDA, for the therapy of esophageal...
Cipla, a renowned global pharmaceutical company, reported a high consolidated net profit growth of 79% to Rs. 932 crore in the fourth quarter ended March 2024, compared to Rs. 522 crore in the same time last year. Its earnings before tax and...
, CDSCO.jpg)
